SMB has advised RApport Global Strategic Services on its sale to ELIQUENT Life Sciences

22nd January 2024

We are pleased to announce the sale of international regulatory consultancy, RApport Global Strategic Services Ltd to US based ELIQUENT Life Sciences.

Our team was led by Peter Weiss, joint head of SMB’s Corporate, Commercial and Finance team, together with legal director Jenny Constable, associate (New Zealand qualified) Tim Graham, and Employment senior associate Krista Barnes advising Lorna Griffin and Ifty Saiyed, founders of RApport, on the sale.

RApport is a specialist international regulatory consultancy offering a range of services to the pharmaceutical, biotechnological and medical device industries.

“We are delighted for the RApport Team and wish them well for this exciting new venture to develop even further on their journey as part of ELIQUENT Life Sciences,” commented Peter Weiss.

Following the acquisition, the Validant group has announced a strategic repositioning that unites its global regulatory consultancies as one global regulatory brand: ELIQUENT Life Sciences.  More information on the new ELIQUENT brand can be found here.

We wish our clients at RApport every success in the future. For further information please contact: